2/28/23 18:28 | 2/25/23 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | M.d | 0 | 0.00 | 0 | 4 | 9 | 48 | D | | | | | | | | | | | | | | |
2/28/23 18:28 | 2/27/23 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | S.d | -4 | 1.68 | 0 | -2 | -4 | 48 | D | | | | | | | | | | | | | | |
11/29/22 17:25 | 11/25/22 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | M.d | 0 | 0.00 | 0 | 4 | 10 | 46 | D | | | | | | | | | | | | | | |
11/29/22 17:25 | 11/28/22 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | S.d | -6 | 2.72 | 0 | -2 | -4 | 46 | D | | | | | | | | | | | | | | |
8/29/22 21:18 | 8/25/22 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | M.d | 0 | 0.00 | 0 | 4 | 10 | 44 | D | | | | | | | | | | | | | | |
8/29/22 21:18 | 8/26/22 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | S.d | -9 | 4.01 | 0 | -2 | -5 | 44 | D | | | | | | | | | | | | | | |
5/27/22 17:32 | 5/25/22 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | M.d | 0 | 0.00 | 0 | 4 | 11 | 42 | D | | | | | | | | | | | | | | |
5/27/22 17:32 | 5/26/22 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | S.d | -4 | 1.90 | 0 | -2 | -5 | 42 | D | | | | | | | | | | | | | | |
3/1/22 21:12 | 2/25/22 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | M.d | 0 | 0.00 | 0 | 4 | 11 | 40 | D | | | | | | | | | | | | | | |
3/1/22 21:12 | 2/28/22 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | S.d | -7 | 2.78 | 0 | -2 | -6 | 40 | D | | | | | | | | | | | | | | |
11/29/21 19:50 | 11/25/21 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | M.d | 0 | 0.00 | 0 | 8 | 27 | 38 | D | | | | | | | | | | | | | | |
11/29/21 19:50 | 11/26/21 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | S.dm | -22 | 4.81 | 0 | -5 | -11 | 38 | D | | | | | | | | | | | | | | |
5/13/21 17:46 | 5/11/21 | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | M.d | 49 | 1.40 | 0 | 35 | New | 35 | D | | | | | | | | | | | | | | |